EU Medicines Agency

Rapid drug discovery http://bit.ly/1oJfEQq  #ribfp7

Today @DIA_Europe what @EMA_news does to address #shortages of #medicines http://bit.ly/1UHELB9 

We have published #PRAC February #minutes http://bit.ly/1NdoU5H 

Presentations from our workshop on #cancer #immunotherapies are now published http://bit.ly/1VDJeE3 

One week left to respond to our questionnaire on our interaction with #academia, deadline 15 April: http://bit.ly/20BJtk0  #consultation

Today @DIA_Europe planning for new #EudraVigilance http://bit.ly/1SOX6sK 

Collecting high-quality data on #antibiotic use in animals: #consultation opens on #ESVAC strategy for 2016-20: http://bit.ly/1PWyidE  #AMR

Today @DIA_Europe Joint Regulatory-HTA #Scientific Advice for more rational development of #medicines http://bit.ly/1UEyfeX 

“We’ve received 19 applications for #PRIME since launch” Jordi Linares @DIA_Europe http://bit.ly/1QFnKRK 

Today @DIA_Europe #PRIME or how we support patient-focused innovation http://bit.ly/1RNe7kK 

The #minutes of the February meeting of our committee for advanced therapies (CAT) are available: http://bit.ly/207Acj7 

Information for applicants applying for EU's Horizon 2020 - New therapies for rare diseases: http://bit.ly/1TBPw79  http://bit.ly/150UJve 

The #minutes of the February meeting of our committee for human medicines (CHMP) are available: http://bit.ly/1WbVpZn 

Assessment report published for #Amlodipine / Valsartan Mylan, a generic medicine for essential hypertension: http://bit.ly/1MRXWpp 

Today @DIA_Europe Regulatory Town Hall on EU #Medicines Agencies Network Strategy to 2020: http://bit.ly/1MNEaeH 

Assessment report for #Zonisamide Mylan, a generic medicine to treat patients with partial seizures, is available: http://bit.ly/1XgxnKS 

18 #medicines recommended for #orphan designation by the #COMP in March: http://bit.ly/1RWcNhv  #rarediseases

EPAR out for #Coagadex a #medicine for the prevention of bleeding episodes in patients with factor X deficiency: http://bit.ly/1VqmBTx